Clinical Utility of Random Anti-TNF Drug Level Testing and Measurement of Anti-Drug Antibodies on Long-Term Treatment Response in Rheumatoid Arthritis.

被引：0

作者：

Jani, Meghna ^{[1
]}

Chinoy, Hector ^{[1
]}

Warren, Richard B. ^{[2
]}

Griffiths, Christopher E. M. ^{[2
]}

Morgan, Ann W. ^{[3
]}

Wilson, Anthony G. ^{[4
]}

Hyrich, Kimme L. ^{[1
]}

Isaacs, John ^{[5
]}

Plant, Darren ^{[1
]}

Barton, Anne ^{[6
]}

机构：

[1] Univ Manchester, Ctr Musculoskeletal Res, Manchester 2, Lancs, England

[2] Univ Manchester, Dermatol Ctr, Manchester, Lancs, England

[3] Univ Leeds, Leeds, W Yorkshire, England

[4] Univ Coll Dublin, Dublin, Ireland

[5] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England

[6] Manchester Acad Hlth Sci Ctr, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England

来源：

ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2924

引用

页码：S1278 / S1278

页数：1

共 50 条

[1] CLINICAL UTILITY OF RANDOM ANTI-TNF DRUG LEVEL TESTING AND MEASUREMENT OF ANTI-DRUG ANTIBODIES ON LONG-TERM TREATMENT RESPONSE IN RHEUMATOID ARTHRITIS
Jani, Meghna
Chinoy, Hector
Warren, Richard B.
Griffiths, Christopher E. M.
Plant, Darren
Fu, Bo
Morgan, Ann W.
Wilson, Anthony G.
Isaacs, John D.
Hyrich, Kimme L.
Barton, Anne
RHEUMATOLOGY, 2015, 54 : 27 - 28
[2] Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis
Jani, Meghna
Chinoy, Hector
Warren, Richard B.
Griffiths, Christopher E. M.
Plant, Darren
Morgan, Ann W.
Wilson, Anthony G.
Hyrich, Kimme L.
Isaacs, John
Barton, Anne
LANCET, 2015, 385 : 48 - 48
[3] Clinical Utility of Random Anti-Tumor Necrosis Factor Drug-Level Testing and Measurement of Antidrug Antibodies on the Long-Term Treatment Response in Rheumatoid Arthritis
Jani, Meghna
Chinoy, Hector
Warren, Richard B.
Griffiths, Christopher E. M.
Plant, Darren
Fu, Bo
Morgan, Ann W.
Wilson, Anthony G.
Isaacs, John D.
Hyrich, Kimme L.
Barton, Anne
ARTHRITIS & RHEUMATOLOGY, 2015, 67 (08) : 2011 - 2019
[4] Clinical Utility and Factors Associated with Certolizumab Pegol Drug Levels and Anti-Drug Antibodies in the Long-Term Treatment of Rheumatoid Arthritis
Jani, Meghna
Chinoy, Hector
Isaacs, John
Morgan, Ann W.
Wilson, Anthony
Hyrich, Kimme L.
Plant, Darren
Barton, Anne
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[5] DETERMINATION OF ANTI-DRUG ANTIBODIES IN LONG-TERM TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS WITH ETANERCEPT
Drynda, S.
Beuermann, R.
Kekow, J.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1033 - 1034
[6] BARRIERS AGAINST TESTING ANTI-TNF DRUG LEVELS AND ANTI-DRUG ANTIBODIES IN ROUTINE CLINICAL PRACTICE
Gavan, S. P.
Daker-White, G.
Payne, K.
Barton, A.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1726 - 1727
[7] ANTI-DRUG ANTIBODIES, DRUG LEVELS AND CLINICAL EFFICACY OF THE ANTI-TNF BIOLOGICS IN RHEUMATIC DISEASES
Mok, C. C.
van der Kleij, D.
Wolbink, G.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 226 - 226
[8] Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNFα biologics in rheumatic diseases
Mok, C. C.
van der Kleij, D.
Wolbink, G. J.
CLINICAL RHEUMATOLOGY, 2013, 32 (10) : 1429 - 1435
[9] Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNFα biologics in rheumatic diseases
C. C. Mok
D. van der Kleij
G. J. Wolbink
Clinical Rheumatology, 2013, 32 : 1429 - 1435
[10] Clinical Utility of Random Anti-Tumor Necrosis Factor Drug-Level Testing and Measurement of Antidrug Antibodies on the Long-Term Treatment Response in Rheumatoid Arthritis (vol 67, pg 2011, 2015)
Gladman, Dafna D.
ARTHRITIS & RHEUMATOLOGY, 2015, 67 (11) : 3096 - 3096

← 1 2 3 4 5 →